The invention provides compositions and methods for treating cancer with glufosfamide in combination with an inhibitor of sodium-glucose transporter type 2 (SGLT2) to block the uptake of glucose in the proximal tubules of the kidneys to decrease renal toxicity. The invention relates to the fields of biomedicine, pharmacology, and molecular biology.
申请公布号
WO2013158143(A1)
申请公布日期
2013.10.24
申请号
WO2012US53275
申请日期
2012.08.31
申请人
ELEISON PHARMACEUTICALS LLC;THOMAS, EDWIN, J.;PARRIS, MATTHEW;ANTHONY, FORREST, H.
发明人
THOMAS, EDWIN, J.;PARRIS, MATTHEW;ANTHONY, FORREST, H.
